Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
US7560437B2 · kind B2 · utility
7Cited by
63References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 11, 2002 |
| Grant date | Jul 14, 2009 |
| Priority date | — |
| Expiry date | Jul 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to pharmaceutical compositions comprising a telomerase reverse transcriptase polypeptide or a polypeptide homologous to a telomerase reverse transcriptase. The present invention is also directed to pharmaceutical compositions comprising a polynucleotide encoding either of the aforesaid polypeptides. The present invention is further directed to methods for eliciting an immune response to telomerase reverse transcriptase in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.